Search clinical trials for: Alemtuzumab (MabCampath)
Total 430 results
-
Genzyme, a Sanofi CompanyTerminatedChronic Lymphocytic LeukemiaMacedonia, The Former Yugoslav Republic of, Bosnia and Herzegovina, Israel
-
Northwestern UniversityGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellJapan
-
CABYCGrupo Español de Linfomas y Transplante Autólogo de Médula ÓseaTerminatedGraft Versus Host DiseaseSpain
-
University of GöttingenCompletedPeripheral T-Cell Lymphoma
-
Central Texas Neurology ConsultantsGenzyme, a Sanofi CompanyUnknown
-
University of British ColumbiaGenzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisCanada
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
Goethe UniversityCompletedLymphoma, Lymphoblastic | Adult Acute Lymphocytic Leukemia T-cellGermany
-
Hospital Universitario Dr. Jose E. GonzalezWithdrawn
-
M.D. Anderson Cancer CenterLeudositeTerminatedLymphoma, B-Cell | Lymphoma, T-Cell | Lymphoma, Low-Grade | Leukemia, Lymphocytic, Acute | Leukemia, Lymphocytic, ChronicUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieSchering-PloughCompletedB-cell Chronic Lymphocytic LeukemiaAustria
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent T-Cell Prolymphocytic Leukemia | T-Cell Prolymphocytic LeukemiaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkins LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Karolinska University HospitalSchering Nordiska ABCompleted
-
Latin American Cooperative Onco-Haematology Group...UnknownMycosis Fungoides | Sezary SyndromePeru
-
University of Illinois at ChicagoRecruitingSickle Cell DiseaseUnited States
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
Genzyme, a Sanofi CompanyCompletedB Cell Chronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupCompleted
-
German CLL Study GroupGenzyme, a Sanofi Company; University of CologneCompletedT-cell-prolymphocytic LeukemiaGermany
-
Dr. Claudia BösmüllerAstellas Pharma GmbHCompletedKidney TransplantationAustria
-
University Hospital MuensterUnknown
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic SyndromesUnited States
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Dr. Claudia BösmüllerAstellas Pharma GmbHCompletedPancreas-Kidney TransplantationAustria
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
Chronic Lymphocytic Leukemia Research ConsortiumBayerUnknownB-Cell Chronic Lymphocytic LeukemiaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedT-LGL Lymphoproliferative DisordersUnited States
-
Johns Hopkins UniversityGenzyme, a Sanofi CompanyWithdrawnChronic Inflammatory Demyelinating NeuropathyUnited States
-
National Institute of Neurological Disorders and...Completed
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Leiden University Medical CenterRecruitingSickle Cell DiseaseNetherlands
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
Samuel Forrester Hunter, MD, PhDUnknownMultiple SclerosisUnited States
-
Weill Medical College of Cornell UniversityBayerCompletedT-Cell Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
University of Wisconsin, MadisonWithdrawnNew Onset Type 1 Diabetes MellitusUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkin's LymphomaUnited States
-
Steven E. CoutreBayerCompletedLeukemia | Chronic Lymphocytic Leukemia (CLL) | Chronic Leukemia | B-cell LeukemiaUnited States
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
St. Jude Children's Research HospitalCompletedSevere Combined ImmunodeficiencyUnited States
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
National Cancer Institute (NCI)CompletedPeripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)United States
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Lymphocytic LeukemiaFrance
-
Leeds Cancer Centre at St. James's University HospitalCompleted